LEXARIA BIOSCIENCE CORP. Property, Plant and Equipment, Other, Net
LEXARIA BIOSCIENCE CORP. (LEXX) had Property, Plant and Equipment, Other, Net of $261.89 thousand as of 2025-02-28, per its 10-Q filed 2025-04-14.
Financial Statements › Notes › and Equipment › Property, Plant, and Equipment, Other, after Accumulated Depreciation
us-gaap:PropertyPlantAndEquipmentOtherNet · last filed 2025-04-14
- 2025-02-28: Property, Plant and Equipment, Other, Net $261.89K.
- 2024-11-30: Property, Plant and Equipment, Other, Net $270.62K.
- 2024-08-31: Property, Plant and Equipment, Other, Net $254.71K.
- 2024-05-31: Property, Plant and Equipment, Other, Net $219.29K.
| Period end | Property, Plant and Equipment, Other, Net |
|---|---|
| 2025-02-28 | $261.89K 10-Q · filed 2025-04-14 |
| 2024-11-30 | $270.62K 10-Q · filed 2025-01-10 |
| 2024-08-31 | $254.71K 10-Q · filed 2025-04-14 |
| 2024-05-31 | $219.29K 10-Q · filed 2024-07-12 |
| 2024-02-29 | $226.31K 10-Q · filed 2024-04-09 |
| 2023-11-30 | $233.64K 10-Q · filed 2024-01-12 |
| 2023-08-31 | $254.14K 10-K · filed 2024-11-26 |
| 2023-05-31 | $276.90K 10-Q · filed 2023-07-14 |
| 2023-02-28 | $301.42K 10-Q · filed 2023-04-14 |
| 2022-11-30 | $311.22K 10-Q/A · filed 2023-01-18 |
| 2022-08-31 | $315.50K 10-K · filed 2023-11-20 |
| 2022-05-31 | $343.43K 10-Q · filed 2022-07-14 |
| 2022-02-28 | $358.81K 10-Q · filed 2022-04-11 |
| 2021-11-30 | $384.14K 10-Q · filed 2022-01-14 |
| 2021-08-31 | $368.21K 10-K · filed 2022-11-28 |
| 2021-05-31 | $395.40K 10-Q · filed 2021-07-15 |
| 2020-08-31 | $483.36K 10-Q · filed 2022-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |